BioCryst Pharmaceuticals (BCRX) Stock Sinks As Market Gains: What You Should KnowZacks Investment Research • 04/27/20
BioCryst's Galidesivir: A Promising Candidate Drug In The Race To COVID-19 TreatmentSeeking Alpha • 04/16/20
Biocept To Begin COVID-19 Testing Wednesday, BioCryst, Athersys, Can-Fite To Research Potential Treatments In ClinicsBenzinga • 04/13/20
BioCryst Begins Clinical Trial with Galidesivir for Treatment of Patients with COVID-19GlobeNewsWire • 04/09/20
European Medicines Agency Validates Marketing Authorization Application for Oral, Once-Daily Berotralstat (BCX7353) to Prevent HAE AttacksGlobeNewsWire • 03/30/20
BioCryst: Take Advantage Of Current Extreme Volatility To Buy At Bargain PricesSeeking Alpha • 03/17/20
BEROTRALSTAT (BCX7353) SIGNIFICANTLY REDUCED USE OF ACUTE ON-DEMAND MEDICINE IN HAE PATIENTS IN APEX-2GlobeNewsWire • 03/16/20
BioCryst Pharmaceuticals, Inc. (BCRX) CEO Jon Stonehouse on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/05/20
BioCryst Begins Proof of Concept Trial in PNH Patients With Oral Factor D Inhibitor, BCX9930GlobeNewsWire • 03/05/20